In summary, based on the results we obtained from the MI/R animal model, we propose here that inhibiting TRIM6 expression and/or activity or interfering IKKε-dependent STAT1 activation may present a potential therapeutic option in reducing the size of myocardial infarct and alleviating MI/R injury. Here, TRIM6 is linked to myocardial infarction.